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Abstract
We evaluated the expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), ionized calcium binding adap-
tor protein-1 (Iba-1), and ferritin in rats after single or repeated lipopolysaccharide (LPS) treatment, which is known to induce 
endotoxin tolerance and glial activation. Male Wistar rats (200-250 g) received ip injections of LPS (100 µg/kg) or saline for 
6 days: 6 saline (N = 5), 5 saline + 1 LPS (N = 6) and 6 LPS (N = 6). After the sixth injection, the rats were perfused and the 
brains were collected for immunohistochemistry. After a single LPS dose, the number of GFAP-positive cells increased in the 
hypothalamic arcuate nucleus (ARC; 1 LPS: 35.6 ± 1.4 vs control: 23.1 ± 2.5) and hippocampus (1 LPS: 165.0 ± 3.0 vs control: 
137.5 ± 2.5), and interestingly, 6 LPS injections further increased GFAP expression in these regions (ARC = 52.5 ± 4.3; hip-
pocampus = 182.2 ± 4.1). We found a higher GS expression only in the hippocampus of the 6 LPS injections group (56.6 ± 
0.8 vs 46.7 ± 1.9). Ferritin-positive cells increased similarly in the hippocampus of rats treated with a single (49.2 ± 1.7 vs 28.1 
± 1.9) or repeated (47.6 ± 1.1 vs 28.1 ± 1.9) LPS dose. Single LPS enhanced Iba-1 in the paraventricular nucleus (PVN: 92.8 
± 4.1 vs 65.2 ± 2.2) and hippocampus (99.4 ± 4.4 vs 73.8 ± 2.1), but had no effect in the retrochiasmatic nucleus (RCA) and 
ARC. Interestingly, 6 LPS increased the Iba-1 expression in these hypothalamic and hippocampal regions (RCA: 57.8 ± 4.6 vs 
36.6 ± 2.2; ARC: 62.4 ± 6.0 vs 37.0 ± 2.2; PVN: 100.7 ± 4.4 vs 65.2 ± 2.2; hippocampus: 123.0 ± 3.8 vs 73.8 ± 2.1). The results 
suggest that repeated LPS treatment stimulates the expression of glial activation markers, protecting neuronal activity during 
prolonged inflammatory challenges.
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Lipopolysaccharide (LPS), a Gram-negative bacterial 
cell surface component, has been used to stimulate the 
immune response both in peripheral tissues (1) and in the 
brain (2). It is well known that LPS increases the immunos-
taining for glial marker proteins, coupled with production of 
tumor necrosis factor-α (TNF-α) (3), interleukin-1β (IL-1β) 
(4) and nitric oxide (5). In contrast, earlier reports demon-
strated that long-term administration of LPS is accompanied 
by a tolerance to its effects, with desensitization of single 
LPS-induced responses (6-8). Nevertheless, little is known 
about the effect of chronic exposure to LPS on glial marker 
expression in vivo. 
Reactive glia and the products induced by these cells 
are the most likely candidates for mediating inflamma-
tion in the brain. Upon activation, glial cells change their 
morphology and up-regulate the expression of a variety of 
cell-type selective markers, such as glial fibrillary acidic 
protein (GFAP) (2,9), glutamine synthetase (GS) (10), 
ionized calcium binding adaptor protein-1 (Iba-1) (11,12), 
and ferritin (13). Two groups of glial cells are presented in 
the brain: the macroglia, including astrocytes and oligo-
dendrocytes, and the microglia. Astrocytes affect central 
nervous system (CNS) homeostasis through neurotrophic 
factor release that in turn affects neuronal function (14). 
Astrocytes undergo astrogliosis, characterized by an en-
hancement of GFAP expression in several neurodegenera-
tive diseases (15). Astrogliosis can be a beneficial event 
to promote neuronal growth and survival, but it may also 
be damaging (16). However, the molecular mechanism 
underlying GFAP expression in activated astrocytes is 
poorly understood. Another important role of astrocytes is 
to take up excess ammonia and to convert glutamate into 
glutamine via the GS enzyme, protecting neurons against 
excitotoxicity (17). Thus, changes in GS expression may 
indicate alterations in astrocyte function. Of note, glial GS 
may also be involved in pathological brain conditions such 
Expression of glial cell activity markers during inflammation 785
www.bjournal.com.br Braz J Med Biol Res 45(8) 2012
as Alzheimer’s disease (18). 
Some specific microglial markers are used to discriminate 
microglia from astrocytes. Imai et al. (19) isolated a rat cDNA 
clone encoding a novel gene designated iba1 (ionized calcium 
binding adapter molecule-1). The genomic copy of the iba1 
gene is located within a segment of the major histocompat-
ibility complex class III. Among brain cells, the iba1 gene 
was expressed specifically in the microglia cells and Iba-1 
protein is suggested to act as an adaptor molecule, mediat-
ing calcium signaling in these cells. Reports have pointed 
out that active microglia and oligodendrocytes also express 
iron management proteins such as ferritin (13,20). Ferritin 
peptide contains 24 subunits of heavy (H) or light (L) chain 
(21), which differ functionally. H-ferritin converts soluble fer-
rous iron into the storable ferric form, while L-ferritin stores 
iron at a lower rate. Observations have suggested that the 
iron status of glial cells could influence physiological brain 
responses, since iron is essential for energy production, but 
may also generate reactive oxygen species (13). 
A direct comparison of GFAP, GS, ferritin, and Iba-1 
expression between acute and chronic experimental LPS 
infection in rodents is lacking. Therefore, in this study we 
investigated the expression of selected glial protein markers 
in the CNS of animals after single or repeated LPS exposure 
in order to clarify the role of glial cells in the mechanisms of 
tolerance to endotoxin. 
Material and Methods
Animals
Male Wistar rats weighing 200-250 g (Central Animal Facility 
of Universidade de São Paulo, Ribeirão Preto Campus) were 
individually housed in a light- (12 h on, 12 h off) and tempera-
ture- (23 ± 1°C) controlled room with food and water available 
ad libitum. Rats were allowed to habituate to their environment 
for at least 3 days prior to the experimental procedures. During 
this period, rats were handled daily. All experimental protocols 
were approved by the Ethics Committee for Animal Use of 
Faculdade de Medicina de Ribeirão Preto.
Animal treatment protocol
The LPS from Escherichia coli used in this study was 
purchased from Sigma, USA (Serotype 026:B6). LPS was 
diluted in sterile saline (0.15 M NaCl) and injected ip at the 
dose of 100 µg/kg, in a volume of 1 mL/kg. The LPS or saline 
(1 mL/kg) injection was made between 4:00 and 4:30 pm.
Experimental procedure
GFAP, GS, ferritin, and the Iba-1 protein immunostaining 
after single or repeated LPS injections. For the experiments, 
rats were assigned to three different groups of ip treatment 
(N = 5-6, per group): 1) saline once daily for 6 days (6 
saline); 2) saline once daily for 5 days and an injection of 
LPS on the 6th day (5 saline + 1 LPS), and 3) LPS once 
daily for 6 days (6 LPS). 
Twenty-four hours after the last injection, animals were 
anesthetized with an overdose of 2,2,2-tribromoethanol 
(2.5%, 1 mL/100 g ip; Aldrich, USA) and transcardially 
perfused first with 200 mL saline, followed by 300 mL 4% 
formaldehyde in 0.1 M phosphate buffer. The brain was 
collected, postfixed in the same fixative for 24 h, placed in 
PBS containing 30% sucrose, and stored at 4°C. 
Immunohistochemistry
Coronal brain sections were cut at 30 µm thickness and 
free-floating preserved in cryoprotectant at -20°C. One of 
every fifth section was used for each glial marker immunos-
taining. Briefly, after removal of the sections from the cryopro-
tectant and rinsing in 50 mM KPBS, pH 7.4, sections were 
incubated for 1 h at room temperature, then for 48 h at 4°C 
with primary antibody rabbit anti-GFAP (monoclonal, 1:1000; 
Zymed Laboratories, USA) or mouse anti-GS (monoclonal, 
1:500; Chemicon, USA) or rabbit anti-Iba-1 (monoclonal, 
1:5000, Wako Chemicals, USA) or human anti-ferritin (poly-
clonal, 1:5000, Sigma). After rinsing, sections were incubated 
for 1 h with biotinylated secondary goat anti-rabbit antibody for 
GFAP (1:600) and Iba-1 (1:200), rabbit anti-human antibody 
for ferritin (1:200), or goat anti-mouse antibody for GS (1:200) 
(Vector Laboratories, USA), and processed by the Vectastatin 
Elite avidin-biotin immunoperoxidase method. Solutions of 
diaminobenzidine, nickel sulfate, and H2O2 were used to 
generate blue-black immunolabeling. We also performed 
immunostaining with the primary antibodies described above 
and the secondary donkey anti-mouse CY5 antibody (1:500, 
Jackson, USA) or FITC donkey anti-rabbit antibody (1:500, 
Jackson) for qualitative immunofluorescence.
The photomicrographs were captured with a Leica micro-
scope equipped with a DC 200 digital camera, attached to a 
contrast enhancement device. The immunoreactive-positive 
cells of three sections per rat were estimated by counting 
black staining from an area at the level of the paraventricular 
(PVN), arcuate (ARC) and retrochiasmatic (RCA) nuclei in 
the hypothalamus and hippocampus, using the Image J® 
software (Version 1.38, NIH, USA). We considered the co-
ordinates supplied by Paxinos and Watson atlas (22): PVN 
and RCA at level -1.80 mm from bregma and ARC and hip-
pocampus at level -2.12 to -3.30 mm from bregma. 
Statistical analysis 
Data are reported as means ± SEM. One-way ANOVA 
followed by the Bonferroni post hoc test was used for analysis 
of the number of positive immunolabeled cells. Significance 
was set at P < 0.05.
Results
Expression of GFAP in the hypothalamus and 
hippocampus after single or repeated LPS injection
A single dose of LPS induced a significant increase in 
the number of GFAP-positive cells compared to 6 saline-
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treated rats in the ARC and in the hippocampus (Figure 1). 
Repeated exposure to LPS induced a further enhancement 
(P < 0.05) of GFAP-positive cells in the ARC and hippocam-
pus compared to 6 saline- or single LPS-treated animals. 
There was no difference in GFAP-positive cells in the PVN 
between the saline and LPS-treated groups.
Expression of GS in the hippocampus after single or 
repeated LPS injections 
A single dose of LPS induced no alteration in the num-
ber of GS-positive cells in the hippocampus compared 
to 6 saline rats (Figure 2). On the other hand, 6 doses of 
LPS increased (P < 0.05) the number of GS-positive cells 
in the hippocampus compared to controls and to the single 
LPS treatment. No changes in GS immunostaining were 
observed in any other brain regions investigated.
Expression of ferritin in the hippocampus after 
single or repeated LPS injections 
We observed that a single LPS injection and also 6 LPS 
injections induced a significant increase (P < 0.05) in the 
number of ferritin-positive cells in the hippocampus (Figure 
3) compared to 6 saline-treated rats. We did not observe 
changes in ferritin immunostaining in the hypothalamus.
Expression of Iba-1 in the hypothalamus and 
hippocampus after single or repeated LPS injections 
Our results show that a single dose of LPS increased 
(P < 0.05) the number of Iba-1-positive cells compared to 6 
saline rats, only in the PVN and hippocampus (Figures 4 and 
5). On the other hand, repeated LPS injections increased (P 
< 0.05) the Iba-1-expressing cells in the RCA, ARC, PVN, 
and hippocampus compared to control rats.
Discussion
In the present study, 24 h after a single exposure to LPS, 
animals showed a higher number of GFAP-, ferritin- and 
Iba-1-positive cells in the hippocampus and GFAP- and 
Iba-1-positive cells in the hypothalamus, with no change in 
Figure 1. Panel A, Number of glial fibrillary acidic protein (GFAP)-positive cells in the arcuate (ARC) nucleus and hippocampus 
of animals injected with 6 doses of saline (6 saline), a single dose of lipopolysaccharide (LPS; 5 saline + 1 LPS) or repeated 
doses of LPS (6 LPS). Panel B, Representative photomicrographs showing the distribution of astrocyte GFAP immunostain-
ing (green) in the medial portion of the ARC nucleus (left column) and hippocampus (right column) in animals injected with 6 
doses of saline (6 saline), a single dose of LPS (5 saline + 1 LPS) or repeated doses of LPS (6 LPS). Insets show the areas 
where the photomicrographs were taken at higher magnification (100X). 3V = third ventricle. Data are reported as means ± 
SEM and are representative of two independent experiments (N = 5-6). *P < 0.05 (one-way ANOVA, followed by the Bonfer-
roni post hoc test).
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the number of GS-positive cells. Repeated LPS stimulation 
induced a further increase in GFAP and Iba-1 expression 
in the hypothalamus and hippocampus. We also found that 
repeated LPS treatment induced a marked enhancement of 
GS and ferritin expression in the hippocampus compared 
to controls. 
GFAP seems to have specific patterns of up-regulation 
induced by systemic LPS injection, as we observed both in 
the hypothalamic ARC and hippocampus. Similarly, Herber 
et al. (2) showed an enrichment of astrogliosis in the hip-
pocampus after acute centrally injected LPS. In our results, 
long-term exposure to LPS exacerbated the astrogliosis 
both in the hypothalamus and hippocampus, showing no 
desensitization of astrocytic responses following repeated 
LPS injections. Although the exact mechanism of GFAP 
stimulation remains unclear, our data are consistent with 
the well-recognized function of astrocytes in immune and 
inflammatory challenges in the CNS (14,23). Astrocytes 
account for the improvement of the number of functional 
synapses in the CNS (24) and this could be important to 
maintain the actions of inflammatory mediators during both 
acute and chronic endotoxemia. Moreover, astrocytes 
contribute to the structural and functional integrity of the 
blood brain barrier (BBB) (14). Our observation of marked 
GFAP expression in the ARC suggests that astrocytes could 
also preserve the function of regions close to the median 
eminence, in which BBB is not present, under acute or 
frequent LPS exposure. 
We observed for the first time that after recurrent LPS 
treatment in rodents there is a remarkable enhancement of 
GS expression in the hippocampus, in contrast to single LPS 
treatment. Studies have pointed out that excessive produc-
tion of glutamate, an excitatory amino acid neurotransmit-
ter, induces neurodegeneration and damage in neurologic 
function (25,26) and astrocytes seems to protect neurons 
against glutamate-induced neurotoxicity by the expression 
of GS (27). Therefore, the increased GS expression in the 
hippocampus may be a neuroprotective mechanism during 
repeated exposure to endotoxin. In vivo acute LPS increased 
GS activity by 250% in adult rats (28). However, it has been 
shown that in primary astroglial cultures LPS down-regulated 
GS-mRNA and GS expression with a transitory increase 
in IL-1β mRNA expression (29). Chao et al. (27) observed 
that TNF-α inhibited GS activity in mixed neuronal/astrocyte 
and enriched astrocyte cultures. We previously observed 
that acute LPS treatment increased plasma TNF-α, and rats 
under repeated LPS stimulation showed desensitization of 
the TNF-α response, with no TNF-α enhancement (7). The 
Figure 2. Panel A, Graph showing the number of glutamine synthetase (GS)-positive cells in the hippocampus of animals injected with 
6 doses of saline (6 saline), a single dose of lipopolysaccharide (LPS; 5 saline + 1 LPS) or repeated doses of LPS (6 LPS). Panel B, 
Representative photomicrographs showing the distribution of glial GS immunostaining (red) in the hippocampus. Insets show the areas 
where the photomicrographs were taken at higher magnification (100X). Data are reported as means ± SEM and are representative of 
two independent experiments (N = 5-6). *P < 0.05 (one-way ANOVA, followed by the Bonferroni post hoc test). 
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absence of alteration in GS expression in the single LPS 
group could be, at least in part, a result of TNF-α inhibition. 
Furthermore, glial cells can produce glutamine synthetase 
in response to several stimuli such as insulin, corticosteroid 
hormones, thyroid hormones, and hyperammonemic condi-
tions (10), and these stimuli are affected by LPS. 
We observed in the hippocampus a large number of 
ferritin-expressing cells after single and repeated LPS 
injection. Inflammation affects iron metabolism and many 
inflammatory mediators act via iron-responsive proteins. 
Ferritin was primarily considered to be an iron storage pro-
tein, and recently it was demonstrated that it can deliver iron 
to multiple organs, including the brain (30). It is known that 
inflammatory conditions decrease iron levels in blood (31) 
due to retention of iron within the cells. This phenomenon 
could be a defense reaction to deprive invading pathogens 
of iron, in parallel to an antioxidant defense. Duvigneau et 
al. (32) reported that iron metabolism is expected to be 
modulated in LPS-induced septic shock, since cytokine and 
nitric oxide are produced upon LPS stimulation, and both 
Figure 3. Panel A, Graph showing the number of ferritin-positive cells in the hippocampus of animals injected with 6 doses of 
saline (6 saline), a single dose of lipopolysaccharide (LPS; 5 saline + 1 LPS) or repeated doses of LPS (6 LPS). Panel B, Rep-
resentative bright field photomicrographs showing the distribution of ferritin immunostaining (black staining). Data are reported 
as means ± SEM and are representative of two independent experiments (N = 5-6). *P < 0.05 (one-way ANOVA, followed by the 
Bonferroni post hoc test). 
Figure 4. Number of ionized calcium binding adaptor protein-1 
(Iba-1)-positive cells in the retrochiasmatic (RCA), arcuate (ARC) 
and paraventricular (PVN) nuclei, and hippocampus of animals 
injected with 6 doses of saline (6 saline), a single dose of lipopoly-
saccharide (LPS; 5 saline + 1 LPS) or repeated doses of LPS (6 
LPS). Data are reported as means ± SEM and are representative 
of two independent experiments (N = 5-6). *P < 0.05 (one-way 
ANOVA, followed by the Bonferroni post hoc test). 
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of them could influence iron-responsive proteins. Zhang et 
al. (1) showed that injection of LPS into the globus pallidus 
of rats substantially increased iron levels in glial cells of the 
substantia nigra pars reticulata, suggesting that LPS inflam-
mation leads to stress of dopamine-containing neurons, 
increasing brain vulnerability to degenerative processes. 
The enhancement of ferritin expression in animals with 
short- or long-term exposure to LPS observed in our study 
could account for a protective effect on the CNS.
Our observations indicate an increased number of cells 
immunoreactive to the Iba-1 protein in the hypothalamus 
and hippocampus in response to acute LPS. For the first 
time, we showed a higher number of Iba-1-positive cells in 
these regions elicited by repeated LPS treatment. Microglia 
in the CNS were found to respond rapidly to pathogens 
and also to be involved in several components of the 
neuroinflammatory response. Our data regarding LPS in-
duction of Iba-1 are consistent with published reports (11), 
and the present study adds further evidence of microglia 
participation in response to inflammation, as shown by 
the enhancement of Iba-1 expression during prolonged 
inflammatory challenge. The contribution of microglia to 
the modulation of neurogenesis under pathological con-
ditions has both pro- and anti-neurogenic effects. Cacci 
et al. (33) demonstrated that acutely activated microglia 
prevented neuronal differentiation and strongly increased 
glial differentiation mediated by proinflammatory cytokines, 
whereas chronically activated microglia were shown to be 
permissive to neuronal differentiation and cell survival with 
preserved glial differentiation. These data suggest that, in 
a chronically altered environment, persistently activated 
microglia can have protective functions that favor rather 
than hinder brain repair processes.
Glial cells are known to regulate innate immunity and 
participate in adaptive immune responses in CNS tissue. 
In response to injury, ischemia and inflammatory stimuli, 
Figure 5. Representative photomicrographs showing the distribution of microglial ionized calcium binding adaptor protein-1 
(Iba-1) immunostaining (green) in the medial portion of the arcuate nucleus (ARC; left column), paraventricular nucleus (PVN; 
middle column) and hippocampus (right column) of animals injected with 6 doses of saline (6 saline), a single dose of lipopoly-
saccharide (LPS; 5 saline + 1 LPS) or repeated doses of LPS (6 LPS). Insets show the areas where the photomicrographs 
were taken at higher magnification (100X). 3V = third ventricle
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glial cells may have an activated phenotype associated with 
proliferation, migration to the site of injury and secretion of 
both neurotoxic and neurotrophic factors. Chen et al. (34), 
using short- or long-course LPS treatment with either low 
(250 μg/kg) or high (32 mg/kg) LPS dose, found that dur-
ing repeated exposure to endotoxin, LPS-induced TNF-α, 
IL-1β and IL-6 expression was sustained in the brain even 
though cytokines were no longer induced at the periphery. 
Our findings of a higher expression of glial markers are 
therefore in line with the sustained brain cytokine levels 
observed after long-course LPS treatment. To verify the 
role of glial activity and its relationship with the severity of 
systemic endotoxemia, further studies will be necessary 
to investigate the effects of high and low doses of LPS on 
expression of markers of glia activity
During long-term LPS endotoxemia, although several 
hormonal and peripheral cytokine responses show the 
phenomenon of endotoxin tolerance, the expression of 
different glial markers is not desensitized, indicating an 
enhanced activation of astrocytes and microglia in different 
CNS regions. The maintenance of glial cell responsiveness 
to endotoxin may contribute to the maintenance of CNS 
functions, thus preserving host survival. 
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